Fertility-Preserving Surgeries in Carcinoma Cervix – What Is the Current Evidence?

Authors

  • Rajanbabu Anupama
  • Tejal Gorasia Khadakban
  • Dhiraj Khadakban

DOI:

https://doi.org/10.37591/rrjooh.v1i3.1375

Abstract

Cervical cancer is the most common cancer in India. Fourteen percent of the patients diagnosed with cervical cancer in India are under the age of 40. As more women decide to delay childbearing, the number of nulliparous women with cervical cancer may increase. Early-stage cervical cancer has been traditionally treated with radical hysterectomy or radical radiotherapy. Both forms of therapy will not preserve fertility. In 1987, a French surgeon, Professor Dargent, developed a fertility-sparing surgical approach for treating cervical cancer in nulliparous women. This procedure included vaginal radical trachelectomy and laparoscopic pelvic lymphadenectomy for early cervical cancer. Ten years later, abdominal radical trachelectomy was introduced into practice. Many new studies have come up combining neoadjuvant chemotherapy with radical trachelectomy for larger tumors and also studies have described less radical procedures like conisation for treating carcinoma cervix. With these techniques, now women with cervical cancer have a chance to retain their fertility. Through this paper, we are reviewing the current evidence for fertility preserving surgeries in carcinoma cervix.

 

Keywords: cervical cancer, nulliparous women, radical hysterectomy, pelvic lymphadenectomy, neoadjuvant chemotherapy

Downloads

Published

2019-04-12

Issue

Vol. 1 No. 3 (2012)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.